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ABSTRACT1 
Adipocytes (AdCs) and osteoblasts (OBs) are derived from mesenchymal stem cells 2 
(MSCs) and differentiation toward either lineage is both mutually exclusive and 3 
transcriptionally controlled. Recent studies implicate the mammalian target of rapamycin 4 
(mTOR) pathway as important in determining MSC fate, with inhibition of mTOR promoting 5 
OB differentiation and suppressing AdC differentiation. mTOR functions within two distinct 6 
multiprotein complexes, mTORC1 and mTORC2, each of which contains the unique adaptor 7 
protein, raptor or rictor, respectively. While compounds used to study mTOR signalling, such 8 
as rapamycin and related analogues, primarily inhibit mTORC1, prolonged exposure can also 9 
disrupt mTORC2 function, confounding interpretation of inhibitor studies. As a result, the 10 
relative contribution of mTORC1 and mTORC2 to MSC fate determination remains unclear.  11 
In this study, we generated primary mouse MSCs deficient in either Rptor (RapKO) or 12 
Rictor (RicKO) using the Cre/loxP system. Cre-mediated deletion of Rptor or Rictor resulted 13 
in impaired mTORC1 and mTORC2 signalling, respectively. Under lineage-inductive culture 14 
conditions, RapKO MSC displayed a reduced capacity to form lipid-laden AdCs and an 15 
increased capacity to form a mineralised matrix. In contrast, RicKO MSC displayed reduced 16 
osteogenic differentiation capacity and enhanced adipogenic differentiation potential. Taken 17 
together, our findings reveal distinct roles for mTORC1 and mTORC2 in lineage 18 
commitment of MSCs. 19 
 20 
21 
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INTRODUCTION 1 
Mesenchymal stem cells (MSCs) are multipotent progenitor cells that, in response to 2 
extracellular factors and environmental cues, differentiate into several specialised cell types 3 
including adipocytes (AdCs) and osteoblasts (OBs). In vitro, lineage specification can be 4 
guided by inductive culture conditions.  Murine MSC cultures stimulated with glucocorticoid, 5 
insulin and indomethacin differentiate into mature lipid-laden AdCs, whereas cultures 6 
supplemented with a source of inorganic phosphate and glucocorticoid differentiate into 7 
mineralised matrix-producing OBs.  8 
Several signalling pathways have been shown to regulate MSC differentiation in vitro (1-9 
5). The mammalian target of rapamycin (mTOR) pathway is the primary nutrient-sensing 10 
pathway that controls cell growth and metabolism. mTOR plays an important role in the 11 
adipogenic program, as rapamycin, an allosteric mTOR inhibitor, inhibits adipogenesis (6-10) 12 
whilst deletion of TSC2, a negative regulator of mTOR, promotes adipogenesis (10).  13 
The role of mTOR in MSC commitment to other lineages is less clear. Most notably, 14 
rapamycin studies have shown to have both inhibitory (11-16) and stimulatory (17-20) effects 15 
on osteogenesis, a disparity which may reflect the nature of the target cells used. 16 
Furthermore, rapamycin sequesters FKBP12 (21), a negative regulator of TGFβ1 signalling, 17 
and thus the pro-osteogenic effects of rapamycin may be the indirect result of TGFβ1 18 
activation. 19 
mTOR exists in two distinct complexes, mTORC1 and mTORC2, each of which is 20 
defined by the unique adaptor proteins raptor and rictor, respectively. mTORC1 controls 21 
protein synthesis, ribosome biogenesis and nutrient transport (22,23) whereas mTORC2 22 
regulates cell survival, metabolism and cytoskeletal organisation (24). While rapamycin 23 
primarily inhibits mTORC1, prolonged exposure can also disrupt mTORC2 function (25,26), 24 
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confounding data interpretation with respect to MSC differentiation and the role played by 1 
mTORC1 and mTORC2 in osteogenesis. 2 
In the current study we utilised a genetic approach to specifically delete Rptor or Rictor in 3 
primary MSCs and examine the roles of mTORC1 and mTORC2 in osteogenic and 4 
adipogenic MSC differentiation. 5 
 6 
RESULTS 7 
Generation of Rptor and Rictor knockout MSCs. Primary compact bone-derived MSCs 8 




 mice, and infected with a tamoxifen-inducible self-9 
deleting Cre recombinase (CreER
T2
) or empty vector as a control. Tamoxifen (4-OHT) 10 
treatment induced the nuclear translocation of CreER
T2
, resulting in Rptor or Rictor deficient 11 
MSCs, termed RapKO and RicKO, respectively (Fig. 1A).  12 
Protein levels of RPTOR and RICTOR and the activation status of mTORC1 and 13 
mTORC2 downstream effectors was assessed by western immunoblotting. As previously 14 
reported (27-29), low levels of residual RPTOR or RICTOR protein expression in RapKO 15 
and RicKO cells were observed (Fig. 1B). Consistent with disruption of mTORC1 function, 16 
Rptor deletion resulted in decreased S6K phosphorylation, and hyperphosphorylation of 17 
AktThr308, IRS-1 and FOXO1/3a (Fig. 1B). Rictor deletion resulted in ablation of AktSer473 18 
phosphorylation, in keeping with mTORC2 substrate specificity (Fig. 1B).  19 
Loss of Rptor, but not Rictor, impairs MSC proliferation. The effect of Rptor or Rictor 20 
knockout on MSC growth was examined using WST-1 and BrdU assays. RapKO cells 21 
displayed a significant decrease in growth after 3, 5 and 7 days compared to controls (Fig. 22 
1C). In contrast, no difference in proliferation was observed in response to Rictor deletion 23 
(Fig. 1D). 24 
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To determine whether the inhibition of RapKO cell proliferation was associated with an 1 
induction of apoptosis, RapKO and control MSCs were stained with Annexin V and 7-AAD. 2 
Whilst no significant difference in Annexin V labelling was observed, a 2-fold increase in 3 
7-AAD positive cells was evident in RapKO MSCs compared to controls (Fig. 1E).  4 
The roles of Rptor and Rictor in osteogenic and adipogenic MSC differentiation. We 5 
next examined the ability of RapKO and RicKO cells to differentiate into mature OBs and 6 
form a mineralised extracellular matrix (30,31). Under osteoinductive conditions, RapKO 7 
cells displayed a 5-fold increase in mineral formation relative to controls (Fig. 2A), whereas 8 
RicKO cells displayed a 2-fold decrease in mineral formation (Fig. 2B). 9 
In parallel experiments, the potential of RapKO, RicKO and control MSCs to differentiate 10 
into functional AdCs was also assessed. Quantitation of lipid-laden, Nile Red-stained 11 
adipocytes, relative to total cell number, showed that deletion of Rptor induced a 1.8-fold 12 
decrease in AdC formation, whereas deletion of Rictor resulted in a 1.8-fold increase in AdC 13 
formation (Fig. 2C and Fig. 2D). 14 
Loss of Rptor promotes osteogenesis and inhibits adipogenesis. To gain insight into the 15 
molecular mechanisms by which Rptor deletion promotes osteogenic MSC differentiation, 16 
temporal gene expression analyses were performed. Loss of Rptor induced a strong up-17 
regulation of genes involved in OB differentiation including the osteogenic transcription 18 
factors Cbfa-1 (Runx2) and osterix (Sp7), and the marker of OB function, alkaline 19 
phosphatase (Alpl) (Fig. 3A). In inductive differentiation media, Rptor deletion was also 20 
associated with an increase in the expression of BMP-2 and other osteogenic TGFβ 21 
superfamily members such as inhibinβ A chain (Inhba) and inhibinβ E chain (Inhbe). In 22 
contrast, expression of integrin binding sialoprotein (Ibsp) was strongly down-regulated in 23 
RapKO cultures, as was the expression of noggin (Nog), a negative regulator of BMP 24 
signalling (Fig. 3A). 25 
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In parallel experiments, the effect of Rptor deletion on molecular markers of AdC 1 
differentiation and function was also examined. Consistent with the marked inhibition of 2 
AdC formation in RapKO MSCs (Fig. 2C), the expression of Cebpa and Pparg, transcription 3 
factors essential for adipogenesis, and adiponectin (Adipoq), a marker of mature adipocytes, 4 
was down-regulated in RapKO MSCs at all time points examined (Fig. 3B). 5 
Loss of Rictor promotes adipogenesis and inhibits osteogenesis. We also examined the 6 
temporal regulation of adipogenic genes in RicKO and control MSCs during adipogenic 7 
differentiation. Consistent with the induction of AdC formation in RicKO MSCs (Fig 2D), 8 
the expression of Cebpa, Pparγ and Adipoq was strongly up-regulated in RicKO MSCs at all 9 
time points examined (Fig. 4A). Under osteoinductive culture conditions, loss of Rictor was 10 
associated with a down-regulation of Runx2, Sp7, Alpl, Bmp2 and Inhba expression (Fig. 4B), 11 
consistent with the inhibition of osteogenesis observed in RicKO cells (Fig. 2B).  12 
 13 
DISCUSSION 14 
Using Cre-mediated gene deletion and well-established in vitro differentiation assays, we 15 
have shown that mTORC1 and mTORC2 have distinct roles in MSC fate determination. 16 
Consistent with previous studies (reviewed in (32)), deletion of Rptor in MSCs reduced their 17 
adipogenic potential. Under osteoinductive conditions however, Rptor deletion promoted 18 
osteogenic differentiation. This switching between differentiation programs could reflect the 19 
mutual exclusivity of these programs (i.e. enhanced osteogenesis in the absence of mTORC1-20 
mediated PPARγ activation). Alternatively, loss of mTORC1 may maintain the osteogenic 21 
potential of MSCs, in line with studies showing that rapamycin attenuates stem cell aging, 22 
maintaining their self-renewal and osteogenic potential (33-36), and with in vivo studies 23 
showing that deletion of p70S6K (mTORC1 effector) protects against age-related bone loss 24 
(37). 25 
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While further studies are required to characterise the precise mechanism(s) by which 1 
mTORC1 inhibition promotes osteogenesis, our PCR data suggests that BMP signalling is 2 
involved. Many BMPs are strongly pro-osteogenic (reviewed in (38)), however their role in 3 
osteogenesis is complex (39,40), influenced by variables such as dose (41) and BMP receptor 4 
subtype (39,42). 5 
In contrast to RapKO cells, Rictor deletion promoted adipogenesis and inhibited 6 
osteogenesis, which is consistent with a recent siRNA study which showed that mTORC2 7 
regulation of cytoskeletal organisation plays a role in MSC fate determination in response to 8 
mechanical stress (43). These findings suggest that the decreased osteogenic potential of 9 
RicKO cells may be associated with impaired cytoskeletal organisation.  10 
Overall, these findings provide new insight into the role of mTOR signalling in MSC 11 
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FIGURE LEGENDS 1 
 2 
Figure 1. Cre-mediated loss of Rptor and Rictor expression in RapKO and RicKO 3 





 MSCs infected with the CreER
T2
 lentivirus were treated with  5 
4-OHT, to induce Rptor or Rictor knockout, or vehicle as a control. Lysates were prepared 6 
from control, RapKO and RicKO MSCs and western blot analysis performed using 7 
antibodies directed against the proteins indicated. (C, D) RapKO, RicKO and control MSCs 8 
were cultured for 7 days and proliferation assessed using WST-1 and BrdU assays. Both 9 
cumulative WST-1 data (left) and BrdU data from the Day 7 time point (right) are shown, 10 
expressed as the mean ± SD of quintuplicate wells from a representative experiment of three. 11 
**p<0.005, ****p<0.0001, t-test. (E) RapKO cells were stained for the apoptotic markers 12 
Annexin V and 7-AAD, and analysed immediately by flow cytometry.  13 
 14 





 MSCs infected with the CreER
T2
 lentivirus or empty 16 
vector were treated for 8 days with 4-OHT (+) or vehicle (-). (A, B) Treated cells were 17 
cultured under osteoinductive conditions for 21 days and the amount of acid-solubilised 18 
calcium was quantitated and normalised to cell number. Data are expressed as the mean ± SD 19 
of quadruplicate wells from a representative experiment of three. Representative images of 20 
Alizarin Red-stained wells are shown. (C, D) Treated cells were cultured under adipogenic 21 
conditions for 8 days. Adipocytes were visualised using Nile Red, and the number of 22 
adipocytes quantitated and normalised to total cell number. Data are expressed as the mean ± 23 
SD of quadruplicate wells from a representative experiment of three. *p<0.05, **p<0.005, 24 
***p<0.0005, ****p<0.0001, t-test. 25 
 26 
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Figure 3. Loss of Rptor promotes osteogenesis and inhibits adipogenesis. Raptor
fl/fl 
MSCs 1 
infected with the CreER
T2
 lentivirus were treated with vehicle (control) or 4-OHT (RapKO) 2 
for 8 days. (A) Treated cells were cultured under osteogenic conditions for 22 days and RNA 3 
harvested at the indicated time points. The mRNA level of osteogenic genes was examined 4 
by real-time PCR and data were normalised to β-actin. (B) Treated cells were cultured under 5 
adipogenic conditions for 8 days and RNA harvested at the indicated time points. The mRNA 6 
level of adipogenic genes was examined by real-time PCR and data were normalised to β-7 
actin. *p<0.05, **p<0.005, ***p<0.0005, ****p<0.0001, t-test. 8 
 9 
Figure 4. Loss of Rictor promotes adipogenesis and inhibits osteogenesis. Rictor
fl/fl 
MSCs 10 
infected with the CreER
T2
 lentivirus were treated with vehicle (control) or 4-OHT (RicKO) 11 
for 8 days. (A) Treated cells were cultured under adipogenic conditions for 8 days and RNA 12 
harvested at the indicated time points. The mRNA level of adipogenic genes was examined 13 
by real-time PCR and data were normalised to β-actin. (B) Treated cells were cultured under 14 
osteogenic conditions for 22 days and RNA harvested at the indicated time points. The 15 
mRNA level of osteogenic genes was examined by real-time PCR and data were normalised 16 
to β-actin.  *p<0.05, **p<0.005, ***p<0.0005, ****p<0.0001, t-test. 17 
 18 
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MATERIALS AND METHODS 
Compact bone MSC isolation. Murine compact bone MSCs (CB MSCs) were derived 




 mice (1) according to previously 
established protocols (2), with approval from SA Pathology/CALHN and University of 
Adelaide Animal Ethics Committees. Briefly, tibiae and femora from 8-12 mice were 
excised, cleaned thoroughly with a scalpel and epiphyses removed. The bones were then 
pooled, crushed in ice-cold PBS supplemented with 2% FCS and 2 mM EDTA, washed 
several times, chopped into small fragments and digested in 3 mg/mL Type 1 collagenase at 
37
o
C (Worthington Biochemical Corporation, NJ, USA) for 45 minutes on a shaking 
platform.  The resultant cell suspension was filtered through a 70 µm strainer, pelleted by 
centrifugation and lineage depletion performed using a cocktail of biotinylated antibodies to 
CD3, CD4, CD5, CD8, CD11b, Gr-1, B220, Ter-119 (BioLegend, CA, USA), followed by a 
streptavidin-APC conjugate (Invitrogen/ Life Technologies, VIC, Australia). Cells were also 
stained with CD51-PE, CD31-PerCP Cy5.5 (BioLegend), Sca-1-PeCy7 (BD Biosciences, NJ, 
USA), CD45-eF780 (eBioscience, CA, USA), and fluorogold (Invitrogen) to exclude non-
viable cells. Fluorescence Activated Cell Sorting (FACS) was performed to collect Lin-
CD45-CD31-CD51-Sca-1+ cells (FACSAria, Becton Dickinson).  














sulphate, 1 mM sodium pyruvate and 15 mM HEPES (Sigma Aldrich, NSW, Australia) in a 
hypoxic in vitro cabinet (5% O2, 10% CO2, 85% N2, Coy Laboratory Products, MI, USA) at 
37
o
C (2). Cells were passaged by detachment with a 0.05% trypsin-EDTA solution upon 
reaching 80-90% confluence. 
Cre-mediated gene deletion. CB MSCs (passages 2-3) were infected with a lentivirus 
carrying a tamoxifen-inducible self-deleting Cre recombinase (LEGO-CreER
T2
-iG2), or 
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empty vector control (LEGO-iG2) (3) in the presence of 4 µg/mL polybrene. CB MSCs with 
stable lentiviral integration were selected on the basis of GFP expression. Following in vitro 
expansion, cells were treated with 0.5 µM 4-hydroxytamoxifen (4-OHT, Sigma Aldrich) for 8 
days to induce Rptor or Rictor deletion. Ethanol (0.05%) was used as a vehicle control. To 
exclude any 4-OHT-induced effects unrelated to the knockout of Rptor or Rictor, cells 
infected with a LEGO-iG2 vector control, were used in all studies. 




) were seeded into quadruplicate 
wells of a 48-well plate in α-MEM and allowed to adhere overnight. The next day, media 
were replaced with α-MEM supplemented with 20% FCS, 10
-8 
M dexamethasone sodium 
phosphate, 100 µM ascorbate-2-phosphate, 4 mM KH2PO4 (Asia Pacific Speciality 
Chemicals, NSW, Australia), and cells were cultured under hypoxic conditions with media 
changed twice weekly for 22 days. Mineral content was quantified by measuring the 
concentration of Ca
2+
 in acid-solubilised matrix using the Arsenazo kit (Thermo Scientific, 




dsDNA assay (Invitrogen). To visualise calcium deposits, formalin-fixed cultures were 
stained with Alizarin Red S (Sigma Aldrich) for 1 hour, rinsed with water and allowed to air-
dry.  




) were seeded into quadruplicate wells 
of a 48-well plate in α-MEM and allowed to adhere overnight. The next day, media were 
replaced with α-MEM supplemented with 20% FCS, 10
-6 
M dexamethasone sodium 
phosphate, 60 µM indomethacin (Sigma Aldrich) and 1 µg/mL insulin (Novo Nordisk, NSW, 
Australia), and cells were cultured under hypoxic conditions with media changed twice 
weekly for 8 days. To identify and enumerate lipid-laden fat cells, formalin-ﬁxed cells were 
stained with  
25 ng/mL Nile Red (Sigma Aldrich) and 300 nmol/L DAPI (Invitrogen) for 15 minutes. Nile 
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Red-labelled adipocytes and DAPI-stained cell nuclei were visualised using an inverted 
ﬂuorescence microscope (CKX41; Olympus, Japan), and adipocytes and cell nuclei were 
enumerated from multiple images from each well (10x magnification) using Adobe 
Photoshop and Image J software, respectively.  




) were seeded into quintuplicate wells 
of a 96-well plate in α-MEM and allowed to adhere overnight. The number of viable cells 
present was assessed at the indicated time points using the colorimetric reagent WST-1 as per 
manufacturers’ instructions (Roche, NSW, Australia).  




) were seeded into quintuplicate wells of 
a 96-well plate in α-MEM. The number of viable cells present after 7 days was assessed by 
incubating cells with 5-bromo-2'-deoxyuridine (BrdU) for 16 hours and then detecting the 
incorporated BrdU using a colorimetric assay as per manufacturer’s instructions (Roche). 
Apoptosis. CB MSCs were stained with 5 uL Annexin V-PECy7 (eBioscience) and 20 uL 
7-Aminoactinomycin (7-AAD, Invitrogen) for 15 minutes as per manufacturers’ instructions, 
and analysed immediately by flow cytometry (FC-500, Beckman Coulter, CA, USA). Cells 
incubated in either DMSO (100%) or ethanol (80%) for 10 minutes were used as positive 
controls.  
Real-time PCR. Total RNA was isolated using Trizol reagent (Invitrogen) and cDNA 
prepared from 1 µg of total RNA using Superscript III as per manufacturers’ instructions 
(Invitrogen). Real-time PCR was performed using a Rotor-Gene 3000 (Corbett 
Research/Qiagen, VIC, Australia) using RT2 Real-time SYBR Green/ROX PCR master mix 
(Qiagen). Primer sets used in this study: β-actin: Fwd 5’-ttgctgacaggatgcagaag-3’; Rev 5’-
aagggtgtaaaacgcagctc-3’, C/ebpa: Fwd 5’-caagaacagcaacgagtaccg-3’; Rev 5’-
gtcactggtcaactccagcac-3’, Pparg: Fwd 5’-ttttccgaagaaccatccgatt-3’; Rev 5’-
atggcattgtgagacatcccc-3’, Adipoq: Fwd 5’-tgttcctcttaatcctgccca-3’; Rev 5’-
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ccaacctgcacaagttccctt-3’, Runx2: Fwd 5’-atgatgacactgccacctctg-3’; Rev 5’-
atgaaatgcttgggaactgc-3’, Sp7: Fwd 5’-atggcgtcctctctgcttg-3’; Rev 5’-gtccattggtgcttgagaagg-
3’, Alpl: Fwd 5’-gccttaccaactcttttgtgc-3’; Rev 5’-ggctacattggtgttgagctt-3’, Bmp2: Fwd 5’-
gggacccgctgtcttctagt-3’; Rev 5’-tcaactcaaattcgctgaggac-3’, Noggin (Nog): Fwd 5’-
cgagcgagatcaaagggct-3’; Rev 5’-tcctcctcagcttcttgctca-3’,  Ibsp: Fwd 5’-cagtccagggaggcagtg-
3’; Rev 5’-ggaaagtgtggcgttctctg-3’, inhibinβ A chain (Inhba): Fwd 5’-
tgaatgaactcatggagcagacc-3’; Rev 5’-agctggctggtcctcacag-3’, inhibinβ E chain (Inhbe): Fwd 
5’-tacctgaggatcttccgttgc-3’; Rev 5’-tccagttggagtttcacgacg-3’. Changes in gene expression 
were calculated relative to β-actin using the 2
-∆Ct
 method (4).  
Western Immunoblot. Cell lysates were prepared as previously described (5) and 
equivalent amounts of protein (50 µg) were separated on 8% SDS-PAGE gels and transferred 
to PVDF membranes (GE Healthcare, UK). Immunoblotting was performed with the 
following antibodies: phospho-Akt (Thr308), phospho-Akt (Ser473), phospho-p70
S6K
 (Thr 
389), phospho-IRS1 (Ser636/639), phospho-FOXO1(Thr24)/3a(Thr32), total Akt, total 
p70
S6K
, mTOR, Rictor, Raptor (Cell Signaling Technology, MA, USA), and HSP-90 (Santa 
Cruz, TX, USA). Following incubation with appropriate alkaline-phosphatase conjugated 
secondary antibodies, membranes were developed with enhanced chemifluorescence 
substrate (GE Healthcare). Quantitative analysis was performed using Image Quant software 
(Molecular Dynamics,).  
Statistical Analyses. All experiments were performed in triplicate using separate MSC 
harvests, and data are presented as mean ± SD of a representative experiment containing 
quadruplicate (osteogenic and adipogenic differentiation assay) or quintuplicate (proliferation 
assay) wells. Statistical analyses were performed using unpaired t-tests using Microsoft 
GraphPad Prism 6 (GraphPad Software, CA, USA). In all cases, p<0.05 was considered 
statistically significant. 
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